- Home
- CRVS vs EMX Comparison
CRVS vs EMX Comparison
Compare CRVS & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- EMX
- Stock Information
- Founded
- CRVS 2014
- EMX N/A
- Country
- CRVS United States
- EMX Canada
- Employees
- CRVS N/A
- EMX N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- EMX
- Sector
- CRVS Health Care
- EMX
- Exchange
- CRVS Nasdaq
- EMX Nasdaq
- Market Cap
- CRVS 459.0M
- EMX 461.8M
- IPO Year
- CRVS 2016
- EMX N/A
- Fundamental
- Price
- CRVS $7.59
- EMX $4.17
- Analyst Decision
- CRVS Strong Buy
- EMX Strong Buy
- Analyst Count
- CRVS 4
- EMX 2
- Target Price
- CRVS $13.75
- EMX $5.38
- AVG Volume (30 Days)
- CRVS 1.0M
- EMX 959.4K
- Earning Date
- CRVS 11-04-2025
- EMX 11-07-2025
- Dividend Yield
- CRVS N/A
- EMX N/A
- EPS Growth
- CRVS N/A
- EMX N/A
- EPS
- CRVS N/A
- EMX 0.04
- Revenue
- CRVS N/A
- EMX $29,864,000.00
- Revenue This Year
- CRVS N/A
- EMX $11.08
- Revenue Next Year
- CRVS N/A
- EMX $3.72
- P/E Ratio
- CRVS N/A
- EMX $94.03
- Revenue Growth
- CRVS N/A
- EMX N/A
- 52 Week Low
- CRVS $2.54
- EMX $1.65
- 52 Week High
- CRVS $10.00
- EMX $5.39
- Technical
- Relative Strength Index (RSI)
- CRVS 58.78
- EMX 42.11
- Support Level
- CRVS $6.81
- EMX $4.03
- Resistance Level
- CRVS $7.96
- EMX $4.47
- Average True Range (ATR)
- CRVS 0.52
- EMX 0.28
- MACD
- CRVS -0.03
- EMX -0.12
- Stochastic Oscillator
- CRVS 67.50
- EMX 15.83
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.